This inventor holds 1 USPTO granted patent. Top assignee: Oxford Glycosciences (UK) Ltd. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Nick Sinclair Wedd: Innovator in Peptide Sequence Determination
Introduction
Nick Sinclair Wedd is a notable inventor based in Oxford, GB. He has made significant contributions to the field of peptide sequence determination. His innovative approach has led to the development of a unique method that enhances the understanding of peptide structures.
Latest Patents
Wedd holds a patent for a method titled "Method for de novo peptide sequence determination." This invention relates to generating a library of peptides based on a predetermined molecular mass. The method involves defining a set of amino acids that can be present in the peptide and generating an allowed library of all possible sequences. The molecular mass is typically determined using a mass spectrometer, and theoretical fragmentation spectra are calculated for each sequence to aid in determining the amino acid sequence of unknown peptides.
Career Highlights
Nick Sinclair Wedd is associated with Oxford Glycosciences (UK) Ltd, where he applies his expertise in peptide research. His work has contributed to advancements in the understanding of peptide sequences and their applications in various scientific fields.
Collaborations
Wedd has collaborated with notable colleagues, including Raj Bhikhu Parekh and Sally Barbara Prime. These collaborations have fostered a productive environment for innovation and research in peptide science.
Conclusion
Nick Sinclair Wedd's contributions to peptide sequence determination exemplify the impact of innovative thinking in scientific research. His work continues to influence the field and pave the way for future advancements.